HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.05%

Product NDC
72934-2093
11-digit product format
729342093
Labeler code
72934
Product ID
72934-2093_8879f8d5-e9c7-f749-e053-2a95a90a8af5
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.05%
Dosage form
CREAM
Route
TOPICAL
Labeler
Sincerus Florida, LLC
Marketing category
UNAPPROVED DRUG OTHER
Marketing start
2019-05-10
Marketing end
0000-00-00
Substance
TAZAROTENE; HYALURONATE SODIUM
Active strength
0 g/100g; g/100g
Pharmacologic classes
Retinoid [EPC],Retinoids [CS]
NDC exclude flag
No
Listing certified through
2020-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
a107c35c-2cb4-4734-a92b-e9ed5cfc34d6Product name220260220
5993ea1b-833d-fa4b-caad-a0d477537538Product name520250305
c24b0f4e-b27e-8e2b-a129-1b5a6d72c459Product name220231128
18da2240-e326-4d63-90cd-d6bb15f662a0Product name120200604
a32b252c-8cd2-cc4a-c64c-4b9d3916df9eProduct name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
72934-2093-22021-01-29C16284748780-1ba0f9c33-1c16-a910-e053-dadaa90a0b85HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.05%

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
72934-2093-2HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.05%30 g in 1 BOTTLE, PUMPCREAM301

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
72934-2093HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.05% CREAM [SINCERUS FLORIDA, LLC]1Legacy NDC, 1 package rows20190510_8879f8d5-e9c6-f749-e053-2a95a90a8af5.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsStatus
72934-2093-27293420930230 g in 1 BOTTLE, PUMP30 gHistorical